Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

Initially devised to treat epilepsy by reducing seizures ... If these results are replicated in human trials, it could mean ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

Six years after his Alzheimer’s diagnosis, 90-year-old Zelik Bocknek (Zel) refuses to slow down — and he believes his active lifestyle is key to keeping his symptoms at bay.

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

A recent study reveals that a polymer called polyphosphate may stabilize fibrils, protein structures linked to Alzheimer's, Parkinson's, and other neurodegenerative diseases. Researchers used computer ...

The symptoms typically begin with signs of ... The research team suggests that the treatment can help address very early ...

A compassionate, multidisciplinary approach can help manage one of the most complex challenges nursing homes and other long-term care providers face.

There’s currently no cure for dementia, but treatment can help ease symptoms and improve overall ... certain types of dementia, such as Alzheimer’s disease: These medications are called ...

Researchers at Monash University are conducting clinical trials of a drug that promises to be a game-changer for sufferers of ...

Being started on a smaller dose of the approved early Alzheimer’s therapy Kisunla was found to reduce the risk of ARIA-E on imaging scans.

Hallucinations are a fairly common symptom in the advanced stages of Alzheimer’s disease. Treatment options like medications or therapy can help reduce their frequency and effect. Alzheimer’s ...